SBFM
Sunshine Biopharma Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$0.90
+6.98%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.17
- Revenue estimate
- $9.6M
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$1.15
- EPS estimate
- -$1.20
- Revenue actual
- $9.3M
- Revenue estimate
- $8.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -19.1%
- Revenue beats (12Q)
- 3
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$1.20 | -$1.15 | Beat 4.17% | $9.3M |
| May 13, 2026 | -$0.25 | -$0.25 | In line | $8.1M |
| Nov 13, 2025 | -$0.13 | -$0.19 | Miss -46.15% | $9.4M |
| May 15, 2025 | — | -$0.44 | — | $8.9M |
| Aug 16, 2024 | -$7.40 | -$9.94 | Miss -34.32% | $9.3M |
| May 20, 2024 | -$1.04 | -$40 | Miss -3746.15% | $7.5M |
| Nov 13, 2023 | -$0.06 | -$80 | Miss -133233.33% | $6.0M |
| Aug 11, 2023 | -$160 | -$40 | Beat 75.00% | $5.6M |
| Apr 4, 2023 | — | -$3.0K | — | $3.9M |
| Aug 3, 2022 | — | -$60 | — | $150.3K |
| May 6, 2022 | — | -$0.23 | — | $122.6K |
| Mar 21, 2022 | — | $0.19 | — | $85.1K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026